DeFilippis AP et al. |
Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction. |
2013 |
Circ. J. |
pmid:23985963
|
Kapłon-Cieślicka A et al. |
Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes. |
2013 |
Kardiol Pol |
pmid:24065375
|
d'Emmanuele di Villa Bianca R et al. |
Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:24019484
|
Sadilkova L et al. |
The effect of selected pre-analytical phase variables on plasma thromboxane Aâ‚‚ measurements in humans. |
2013 |
Int J Lab Hematol |
pmid:22908995
|
Dharmasaroja PA et al. |
Aspirin nonresponders in patients with ischaemic stroke. |
2013 |
Blood Coagul. Fibrinolysis |
pmid:23429255
|
Carroll RC et al. |
A comparison of VerifyNowR with PlateletMappingR--detected aspirin resistance and correlation with urinary thromboxane. |
2013 |
Anesth. Analg. |
pmid:23302970
|
Olson MT et al. |
Effect of assay specificity on the association of urine 11-dehydro thromboxane B2 determination with cardiovascular risk. |
2012 |
J. Thromb. Haemost. |
pmid:23072449
|
Cesari M et al. |
Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the health aging and body composition study. |
2012 |
J. Gerontol. A Biol. Sci. Med. Sci. |
pmid:22389462
|
Li C et al. |
Reversal of the anti-platelet effects of aspirin and clopidogrel. |
2012 |
J. Thromb. Haemost. |
pmid:22268852
|
Lemkes BA et al. |
The influence of aspirin dose and glycemic control on platelet inhibition in patients with type 2 diabetes mellitus. |
2012 |
J. Thromb. Haemost. |
pmid:22252020
|